10x Genomics (TXG) Gross Profit (2018 - 2026)

10x Genomics has disclosed Gross Profit across 9 years of filings, most recently posting $112.5 million for Q2 2026.

• In Q2 2026, Gross Profit fell 10.06% year-over-year to $112.5 million; the TTM figure through Jun 2026 stood at $432.0 million (down 3.54% YoY), while the FY2025 annual figure was $443.9 million, up 7.09% from the prior year.
• Gross Profit came in at $112.5 million for Q2 2026 at 10x Genomics, up from $106.2 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $125.1 million in Q2 2025 to a low of $86.9 million in Q2 2022.
• Average Gross Profit over 5 years is $104.6 million, with a median of $104.8 million recorded in 2024.
• Year-over-year, Gross Profit decreased 21.66% in 2022 and climbed 20.02% in 2025.
• Over 5 years, Gross Profit stood at $119.4 million in 2022, then declined by 3.03% to $115.8 million in 2023, then dropped by 4.17% to $111.0 million in 2024, then increased by 1.88% to $113.0 million in 2025, then slipped by 0.48% to $112.5 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $112.5 million in Q2 2026, $106.2 million in Q1 2026, and $113.0 million in Q4 2025.